Gernandt & Danielsson advises in Moberg Pharma’s bond issue
The listed pharmaceutical company Moberg Pharma AB (publ) has decided to issue corporate bonds amounting to SEK 300 million through a private placement. The bonds are issued within a framework amount of SEK 600 million. The company has undertaken to list the bonds on Nasdaq Stockholm.
Gernandt & Danielsson has advised the company and its financial advisors Carnegie Investment Bank AB (publ) and Swedbank AB (publ) with a team consisting of Partner Mikael Borg, Senior Associate Adrian Della Morte Pålstam and Associate Katarina Odelberg.Print